{"id":70733,"date":"2026-05-12T10:13:05","date_gmt":"2026-05-12T10:13:05","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70733"},"modified":"2026-05-21T07:14:10","modified_gmt":"2026-05-21T07:14:10","slug":"ghrp-6","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/ghrp-6\/","title":{"rendered":"GHRP-6 Acetaat"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is GHRP-6 Acetate?<\/h3>\n<p style=\"margin: 0;\"><strong>GHRP-6 Acetaat<\/strong> (Growth Hormone Releasing Peptide 6) is a 6-amino-acid synthetic hexapeptide and one of the original growth hormone secretagogues, developed by Bowers and colleagues as the second-generation member of the GHRP series. It acts on the growth hormone secretagogue receptor (GHS-R1a) \u2014 the same receptor as endogenous ghrelin \u2014 producing pulsatile GH release alongside appetite stimulation. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Wat u krijgt bij MedsBase:<\/strong> Onderzoekskwaliteit lyofiliseerde peptiden \u00b7 HPLC \u226599% zuiverheid (COA op aanvraag) \u00b7 Discrete temperatuurstabiele verpakking \u00b7 Wereldwijde peptidekoerier \u00b7 1.400+ geverifieerd <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specificatie<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">87616-84-0 (GHRP-6 free base); supplied as the acetate salt form<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molecuulformule<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>46<\/sub>H<sub>56<\/sub>N<sub>12<\/sub>O<sub>6<\/sub> (free base; acetate salt adds CH<sub>3<\/sub>COOH counterion)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Moleculair gewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">873.02 Da (free base)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequentie<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">His-D-Trp-Ala-Trp-D-Phe-Lys-NH<sub>2<\/sub> (HwAWfK-NH<sub>2<\/sub>, 6 amino acids; contains D-Trp at position 2 and D-Phe at position 5 for proteolytic stability; C-terminally amidated)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized acetate salt (white to off-white powder)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Zuiverheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC geverifieerd, COA op aanvraag)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Opslag<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliseerd: 2\u20138 \u00b0C (koelkast) voor werkvoorraad; \u221220 \u00b0C voor langdurige opslag van ongeopende flesjes. Gereconstitueerd: 2\u20138 \u00b0C, gebruik binnen ~30 dagen. Bescherm tegen licht. Vries de gereconstitueerde oplossing niet in en ontdooi deze niet.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Oplosbaarheid<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatisch water (aanbevolen) of steriel water voor kortere gebruiksperioden<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Onderzoeksgebruik<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Alleen voor laboratoriumonderzoek. Niet voor humaan of veterinair diagnostisch of therapeutisch gebruik.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>What Is GHRP-6 Acetate?<\/h2>\n<p><strong>GHRP-6<\/strong> (Growth Hormone Releasing Peptide 6) is a 6-amino-acid synthetic hexapeptide and one of the canonical members of the growth hormone secretagogue (GHS) peptide class. It was developed by Cyril Y. Bowers and colleagues at Tulane University as part of a structure-activity relationship programme designed to identify small peptides capable of stimulating pulsatile growth hormone release from the anterior pituitary \u2014 work that ultimately led to the discovery of the growth hormone secretagogue receptor and, indirectly, to the identification of endogenous ghrelin as its natural ligand in 1999 by Kojima et al. (Nature). The acetate counterion is used in research-grade lyophilization because it improves long-term peptide stability and aqueous solubility without altering pharmacology.<\/p>\n<p>The well-characterised sequence is HwAWfK-NH<sub>2<\/sub> (where lowercase letters denote D-amino acid residues), molecular weight 873.02\u00a0Da, empirical formula C<sub>46<\/sub>H<sub>56<\/sub>N<sub>12<\/sub>O<sub>6<\/sub>. The two D-amino-acid substitutions (D-Trp at position 2 and D-Phe at position 5) confer resistance to endogenous proteases and extend the in-vivo half-life relative to all-L analogs. The C-terminus is amidated, which is essential for receptor activity. GHRP-6 is <strong>niet goedgekeurd<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. The research-grade GHRP-6 acetate sold here is supplied <strong>uitsluitend voor laboratoriumonderzoek<\/strong> and is not intended for human or veterinary administration. For the newer-generation receptor-selective analog without cortisol\/prolactin signalling, see our <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> product page.<\/p>\n<h2>Mechanism of Action \u2014 GHS-R1a Receptor Agonism and the GH Pulse<\/h2>\n<p>What makes GHRP-6 mechanistically distinctive among growth-axis research peptides is its <strong>selective action on the growth hormone secretagogue receptor<\/strong> \u2014 the same receptor activated by endogenous ghrelin \u2014 rather than the GHRH receptor used by sermorelin and CJC-1295. The downstream effect is a pulsatile rather than tonic pattern of GH release in published research:<\/p>\n<ul>\n<li><strong>GHS-R1a receptor agonism on somatotrophs<\/strong> \u2014 GHRP-6 binds the growth hormone secretagogue receptor type 1a (GHS-R1a, also called ghrelin receptor) on anterior-pituitary somatotrophs. Receptor activation couples to G\u03b1<sub>q\/11<\/sub> and phospholipase C, raising intracellular calcium and triggering depolarisation-coupled exocytosis of GH-containing vesicles. The signal is amplified by suppression of somatostatin tone \u2014 GHRP-6 acts both at the somatotroph and at hypothalamic somatostatin neurons, producing a larger GH pulse than direct somatotroph stimulation alone would predict.<\/li>\n<li><strong>Synergy with endogenous GHRH<\/strong> \u2014 The GHS-R and GHRH-R pathways converge intracellularly but use different second-messenger systems (PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> vs adenylyl cyclase\/cAMP\/PKA), so GHRP-6 and GHRH analogs produce additive or synergistic GH release when combined. This is the rationale for the canonical &#8220;GHRP + GHRH analog&#8221; research combinations: a GHS such as GHRP-6 paired with a GHRH analog such as <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> of <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a>. The combined stimulus produces GH pulses substantially larger than either compound alone.<\/li>\n<li><strong>Off-target appetite stimulation and modest cortisol\/prolactin signal<\/strong> \u2014 Because GHRP-6 acts on the ghrelin receptor, it inherits ghrelin&#8217;s appetite-stimulating effect \u2014 useful in cachexia research, but a confound in cleaner GH-axis pharmacology. GHRP-6 also produces a modest increase in cortisol and prolactin secretion. The newer-generation selective analog Ipamorelin was specifically designed to eliminate this cortisol\/prolactin signal while preserving the GH effect \u2014 see the comparison section below.<\/li>\n<\/ul>\n<p>GHRP-6 has a plasma half-life of approximately 30\u201360 minutes, considerably longer than native ghrelin (~10\u201330 minutes) due to the D-amino-acid substitutions that resist proteolytic cleavage. Subcutaneous administration is the most-cited research route in the published literature; intravenous and intranasal routes are also documented in mechanism-of-action studies.<\/p>\n<h2>Gepubliceerde onderzoeksapplicaties<\/h2>\n<p>GHRP-6 is used in laboratory research contexts that investigate:<\/p>\n<ul>\n<li><strong>Growth hormone axis pharmacology<\/strong> \u2014 pulsatile GH dynamics, somatotroph responsiveness, comparative GH-secretagogue research; benchmark first-generation GHS in published GH-pulse architecture studies (Bowers et al., J Clin Endocrinol Metab; Smith et al., Science 1996)<\/li>\n<li><strong>Appetite and feeding behaviour research<\/strong> \u2014 ghrelin-axis activation, food-intake assays in rodent models, cachexia models in tumour-bearing animals; canonical research tool for separating ghrelin-mediated orexigenic signalling from other appetite pathways<\/li>\n<li><strong>Pituitary function research<\/strong> \u2014 GH reserve testing in preclinical models, somatotroph hypertrophy \/ hyperplasia, mechanism-of-action research for novel GH secretagogues<\/li>\n<li><strong>Cachexia and wasting syndrome research<\/strong> \u2014 tumour-bearing rodent cachexia, COPD-associated wasting models, lean-mass \/ fat-mass preservation through combined GH-axis and appetite-axis activation<\/li>\n<li><strong>Comparative GHS research<\/strong> \u2014 head-to-head benchmarking against newer analogs including <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> (receptor-selective without cortisol\/prolactin), hexarelin (modified GHRP-6), GHRP-2 (alternative first-generation analog), and orally-active small-molecule GHS such as MK-677<\/li>\n<li><strong>Cardiovasculair onderzoek<\/strong> \u2014 GHS-R expression on cardiomyocytes; published research on cardiac ischaemia-reperfusion injury and cardiac function in GH-deficient models<\/li>\n<li><strong>Combined GHRP + GHRH research<\/strong> \u2014 synergistic GH-release protocols pairing GHRP-6 with GHRH analogs such as <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> of <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a> for maximal pulsatile GH research stimulus.<\/li>\n<\/ul>\n<p>For broader context on where GHRP-6 fits within the growth-axis peptide landscape, see <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> as the newer-generation receptor-selective analog, <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a> for long-acting GHRH-axis research, and <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> for shorter-acting GHRH research. Browse the full <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\">onderzoekspeptiden catalogus<\/a> voor gerelateerde verbindingen.<\/p>\n<h2>Beschikbare sterktes en concentraties<\/h2>\n<p>MedsBase stocks GHRP-6 Acetate in two lyophilized vial sizes calibrated to typical research protocol lengths. Each strength is available in 10-vial or 20-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vulsterkte<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typisch Onderzoeksgebruik<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Verpakkingsgroottes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard research strength \u2014 short-cycle GH-pulse protocols, single-cohort studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle protocols, multi-cohort studies, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 of 20 flesjes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when researchers want to minimise injection volume in rodent protocols. Because GHRP-6 dose ranges are in the 50\u2013300\u00a0mcg per administration regime, a single 5\u00a0mg vial supports many weeks of research at typical doses.<\/p>\n<h2>How It Compares \u2014 GHRP-6 vs Ipamorelin<\/h2>\n<p>GHRP-6 and <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> are the canonical first- and third-generation members of the growth hormone secretagogue peptide class, respectively, and are the most-cited head-to-head comparison in published GHS research. They share the same receptor (GHS-R1a) and produce comparable GH pulses, but differ substantially in receptor selectivity and off-target signalling.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHRP-6<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lengte<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">6 amino acids (hexapeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5 amino acids (pentapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Generation<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">First-generation GHS (~1984)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Third-generation GHS (~1998)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Receptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHS-R1a (ghrelin receptor)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHS-R1a (ghrelin receptor)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>GH pulse<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Strong pulsatile GH release<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Strong pulsatile GH release (comparable to GHRP-6)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Appetite signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Yes (ghrelin-like orexigenic effect)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minimal or absent in published research<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cortisol \/ prolactin<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Modest increases (research-relevant confound)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No measurable increase \u2014 the key selectivity gain<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typische onderzoeksdosis<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013300\u00a0mcg, 1\u20133x daily<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013300\u00a0mcg, 1\u20133x daily<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Plasma half-life<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30\u201360 min<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 hours<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For research where the appetite-stimulation signal is a feature (cachexia models, food-intake studies), GHRP-6 is preferred because the orexigenic effect is part of the research target. For clean GH-axis pharmacology where cortisol and prolactin are confounding variables, Ipamorelin is preferred because the receptor-selectivity gains eliminate those off-target signals. Both are frequently paired with a GHRH analog (such as <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a>) for the canonical synergistic GH-pulse research protocol.<\/p>\n<h2>Opslag en Reconstituering<\/h2>\n<p><strong>Voor reconstituering:<\/strong> store lyophilized vials refrigerated at 2\u20138\u00a0\u00b0C in original packaging for short-term working stock. For unopened long-term storage, freeze at \u221220\u00a0\u00b0C. Lyophilized GHRP-6 acetate is stable under refrigeration for up to 24 months and at \u221220\u00a0\u00b0C for up to 36 months. Avoid freeze-thaw cycles on the lyophilized powder.<\/p>\n<p><strong>Reconstitueringsprocedure:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg research dose; 0.1\u00a0mL delivers 250\u00a0mcg. Swirl gently \u2014 do <strong>niet<\/strong> Bewaar gekoeld bij 2\u20138 \u00b0C en gebruik binnen 30 dagen voor optimale stabiliteit. Vries de gereconstitueerde oplossing niet in \u2014 vries-ontdooicycli tasten de peptide-integriteit aan. Gooi elk flesje weg dat troebelheid, neerslag of verkleuring vertoont. Omdat tirzepatide in onderzoeksprotocollen eenmaal per week wordt toegediend, ondersteunt een enkel gereconstitueerd 10 mg-flesje doorgaans 2\u20134 weken dosering, afhankelijk van de doeldosis; een 50 mg-flesje ondersteunt 10\u201320 weken bij klinisch equivalente doseringen.<\/p>\n<p><strong>Na reconstitutie:<\/strong> Bewaar gekoeld bij 2\u20138 \u00b0C en gebruik binnen 30 dagen voor optimale stabiliteit. Vries de gereconstitueerde oplossing niet in \u2014 vries-ontdooicycli tasten de peptide-integriteit aan. Gooi elk flesje weg dat troebelheid, neerslag of verkleuring vertoont.<\/p>\n<h2 id=\"faqs\">Veelgestelde vragen<\/h2>\n<h3>What is GHRP-6 used for in research?<\/h3>\n<p>GHRP-6 is used in laboratory research investigating the growth hormone axis, pulsatile GH release dynamics, somatotroph responsiveness, ghrelin-axis pharmacology, appetite and feeding behaviour, cachexia and wasting syndromes, and combined GHRP + GHRH synergistic GH-release protocols. It is the canonical first-generation GHS research peptide and the structural template from which Ipamorelin and other later-generation analogs were derived. The research-grade GHRP-6 sold here is <strong>niet<\/strong> FDA-goedgekeurd en wordt strikt geleverd voor laboratoriumonderzoek alleen.<\/p>\n<h3>How is GHRP-6 different from Ipamorelin?<\/h3>\n<p>Both act on the same receptor (GHS-R1a, the ghrelin receptor) and produce comparable pulsatile GH release, but they differ substantially in receptor selectivity and off-target signalling. GHRP-6 produces ghrelin-like appetite stimulation and modest increases in cortisol and prolactin. Ipamorelin was specifically designed to eliminate these off-target signals while preserving the GH effect \u2014 it produces minimal appetite signal and no measurable cortisol or prolactin increase in published research. For clean GH-axis pharmacology, Ipamorelin is preferred; for research involving appetite as a target, GHRP-6 remains useful.<\/p>\n<h3>What is the difference between GHRP-6 and GHRP-2?<\/h3>\n<p>Both are first-generation hexapeptide growth hormone secretagogues from the Bowers laboratory programme. GHRP-2 is somewhat more potent on a per-mg basis and produces slightly less appetite signal than GHRP-6, but the qualitative pharmacology is similar \u2014 both raise cortisol and prolactin modestly. GHRP-6 is the more extensively studied of the pair in published research and remains the canonical first-generation reference compound.<\/p>\n<h3>What is the typical GHRP-6 research dose?<\/h3>\n<p>Published preclinical protocols typically use 50\u2013300\u00a0mcg per administration, given subcutaneously 1\u20133 times daily for 2\u201312 week research cycles. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 0.04\u00a0mL equals 100\u00a0mcg, 0.1\u00a0mL equals 250\u00a0mcg.<\/p>\n<h3>Is GHRP-6 FDA approved?<\/h3>\n<p>No. GHRP-6 is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. All GHRP-6 sold by research-use-only suppliers is for laboratory investigation and should not be administered to humans.<\/p>\n<h3>How should GHRP-6 Acetate be stored?<\/h3>\n<p>Gevriesdroogde flesjes: gekoeld bewaren bij 2\u20138 \u00b0C voor kortdurende werkvoorraad, of bij \u221220 \u00b0C voor langdurige opslag van ongeopende flesjes. Gereconstitueerde oplossing: gekoeld bewaren bij 2\u20138 \u00b0C, binnen 30 dagen gebruiken. Bevries de gereconstitueerde oplossing niet \u2014 vries-ontdooicycli degraderen het peptide. Bescherm te allen tijde tegen direct licht.<\/p>\n<h3>How do I reconstitute GHRP-6?<\/h3>\n<p>Volg de hierboven beschreven reconstitutieprocedure. Voeg bacteriostatisch water toe langs de zijkant van het flesje (niet rechtstreeks op het gevriesdroogde poeder), draai voorzichtig en laat 2\u20135 minuten staan voor volledige oplossing. Schud <strong>niet<\/strong> Schud het flesje. Een correct gereconstitueerde oplossing is helder en kleurloos. Voor een flesje van 5 mg + 2,0 mL verdunningsmiddel is de werkconcentratie 2,5 mg\/mL.<\/p>\n<h3>Welke sterktes heeft MedsBase op voorraad?<\/h3>\n<p>MedsBase carries GHRP-6 Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial or 20-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.<\/p>\n<h3>Why does GHRP-6 also stimulate appetite?<\/h3>\n<p>GHRP-6 binds the growth hormone secretagogue receptor (GHS-R1a) \u2014 the same receptor activated by endogenous ghrelin. Because ghrelin is the principal hunger hormone, any agonist of its receptor inherits some degree of orexigenic (appetite-stimulating) activity. For first-generation GHS such as GHRP-6 and GHRP-2, the appetite effect is substantial; for later-generation receptor-selective analogs such as Ipamorelin, the orexigenic signal was successfully attenuated through structural optimisation.<\/p>\n<h3>Can GHRP-6 be paired with a GHRH analog in research?<\/h3>\n<p>Yes \u2014 this is the canonical synergistic GH-pulse research protocol. GHRP-6 activates GHS-R1a (PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> signalling) while GHRH analogs such as <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> of <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a> activate GHRH-R (adenylyl cyclase\/cAMP\/PKA signalling). The two pathways converge on somatotrophs but use different second-messenger systems, producing additive or synergistic GH release when combined.<\/p>\n<h3>Does GHRP-6 cause side effects in research?<\/h3>\n<p>The principal on-target effects are GH release and appetite stimulation. Off-target findings include modest cortisol and prolactin increases (the principal research-relevant confound for GH-axis studies), transient flushing or local injection-site reactions, and (rarely) GHS-R-mediated effects on cardiac function at high doses. The cortisol\/prolactin signal is the main reason newer-generation selective analogs such as Ipamorelin were developed.<\/p>\n<h3>What is the half-life of GHRP-6?<\/h3>\n<p>In preclinical research, GHRP-6 has a plasma half-life of approximately 30\u201360 minutes following subcutaneous administration. The extended half-life relative to endogenous ghrelin (~10\u201330 min) is due to the two D-amino-acid substitutions (D-Trp at position 2 and D-Phe at position 5) that resist proteolytic cleavage. The GH pulse outlasts plasma clearance because somatotroph desensitisation and receptor downregulation are slower processes.<\/p>\n<h3>How long does GHRP-6 take to show effects in preclinical research?<\/h3>\n<p>Acute GH pulses are detectable within 15\u201330 minutes of subcutaneous administration and peak within 60\u201390 minutes. Appetite-stimulation effects on food intake are measurable within hours of administration in rodent models. Downstream effects on IGF-1 production and tissue-level GH-axis signalling accumulate over 1\u20134 weeks of regular dosing.<\/p>\n<h3>Can I order GHRP-6 for international shipping?<\/h3>\n<p>Yes. MedsBase ships GHRP-6 worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking and are covered by our <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Growth-Axis, GH-Release, and Anabolic Research<\/h2>\n<ul>\n<li><a href=\"\/nl\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Third-generation selective GHS pentapeptide \u2014 clean GH pulse without cortisol\/prolactin<\/li>\n<li><a href=\"\/nl\/cjc-1295-with-dac\/\"><strong>CJC-1295 met DAC<\/strong><\/a> \u2014 Long-acting GHRH analog \u2014 canonical GHRH-axis research compound<\/li>\n<li><a href=\"\/nl\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 Shorter-acting GHRH(1-29) analog \u2014 natural GH-pulse research<\/li>\n<li><a href=\"\/nl\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-arginine recombinant IGF-1 analog \u2014 downstream of GH\/IGF axis<\/li>\n<li><a href=\"\/nl\/tesamorelin\/\"><strong>Tesamorelin<\/strong><\/a> \u2014 GHRH-analoog \u2014 onderzoek naar visceraal vetweefsel<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Verder lezen<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the GH-axis peptide landscape<\/strong><\/p>\n<p style=\"margin: 0;\">Bekijk het volledige <a href=\"https:\/\/medsbase.com\/nl\/peptides\/\"><strong>onderzoekspeptiden catalogus<\/strong><\/a>, with related GH-axis compounds including <a href=\"https:\/\/medsbase.com\/nl\/ipamorelin\/\">Ipamorelin<\/a> for clean receptor-selective GHS research, <a href=\"https:\/\/medsbase.com\/nl\/cjc-1295-with-dac\/\">CJC-1295 met DAC<\/a> for long-acting GHRH research, and <a href=\"https:\/\/medsbase.com\/nl\/sermorelin\/\">Sermorelin<\/a> for natural-pulse GHRH research.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 First-generation GHS hexapeptide<br \/>\n\u2705 GHS-R1a \/ ghrelin receptor agonist<br \/>\n\u2705 Stimulates pulsatile GH release<br \/>\n\u2705 Ghrelin-axis appetite research<br \/>\n\u2705 Synergistic with GHRH analogs<\/p>\n<p><strong>GHRP-6 Acetaat<\/strong> bevat synthetisch peptideverbinding.<\/p>","protected":false},"featured_media":70956,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6280,5441],"class_list":{"0":"post-70733","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-ghrp-6","8":"product_tag-peptide","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/70733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=70733"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/70956"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=70733"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=70733"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=70733"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=70733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}